Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. - Wikidata - thesis-toulmin - TriplyDB

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.

http://www.wikidata.org/entity/Q34185186

about

A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action Kappa opioid antagonists: past successes and future prospects Dynorphin, stress, and depression Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2 The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents Kappa-opioid ligands in the study and treatment of mood disorders Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction Dynorphin--still an extraordinarily potent opioid peptide Role of kappa-opioid receptors in stress and anxiety-related behavior.Drug withdrawal conceptualized as a stressor.Biomarkers of epileptogenesis: psychiatric comorbidities (?)Kappa Opioids, Salvinorin A and Major Depressive Disorder The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators New approaches to antidepressant drug discovery: beyond monoamines Characterization of BU09059: a novel potent selective κ-receptor antagonist CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior Bipolar disorder: candidate drug targets.Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.Corticosterone mediates the synaptic and behavioral effects of chronic stress at rat hippocampal temporoammonic synapses.Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonists Salvinorin A analogs as probes in opioid pharmacology.Affective cue-induced escalation of alcohol self-administration and increased 22-kHz ultrasonic vocalizations during alcohol withdrawal: role of kappa-opioid receptors.Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTic.Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.Analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Synthesis and in vitro and in vivo opioid receptor antagonist activity 30 years of dynorphins--new insights on their functions in neuropsychiatric diseases Genetic and early environmental contributions to alcohol's aversive and physiological effects.

P2860

Q24557465-33B9645E-7C9D-4F75-B497-D99405498571 Q24642144-C90289AA-741C-460F-80D6-1C4D4663E954 Q24647830-9448A026-8A78-4E3E-8EC4-450249EA4AF7 Q24650168-A3073226-4B20-4944-B23C-2FC5625D6230 Q24651427-FF935C2D-3427-444B-9405-99AE61D176F1 Q24653810-311F7ADC-1204-45A2-8ECF-DC38F1108ABF Q24655164-0BB7684A-817B-4B37-BFBB-2895A6B4A059 Q24655307-BE0A784C-A187-440E-AF1A-7B6E4BE9DE9D Q24656267-19A6CF93-4C0A-4C69-9D1E-781756BB1017 Q24656590-27D4B168-6441-4CD2-9413-3289E4672439 Q24657982-777D19AD-F5C0-43A7-B09F-843BCFEB0CC9 Q24658266-6B0AD8EE-7BBB-4988-AD3E-480A02DFE5AF Q24685243-6ABCFD9F-D075-4A5B-A410-9E7533B96AD1 Q24685275-8CB6DA14-959C-4E93-9430-41C595E83AFE Q26770785-C6F03F63-1681-4226-B639-3EBD29029783 Q26860519-161529AD-EEAB-42EE-84F8-35EEC63469E5 Q26991739-9F9C3B40-6DB5-4A0F-B70B-DE55D512B62F Q26997989-8F30BF87-E1A9-461F-AC81-C55211EE9AE2 Q27015612-EFE8F2F0-8782-452A-91A8-9A57C07A1EE8 Q28075656-1D9F198A-2121-46AB-A4B1-E1B5DB131D52 Q28243936-E5752892-6FC1-442D-8EC5-92F90297DB34 Q28269018-2B970546-354F-4C6B-BB03-9253DE35DC77 Q28275620-9492A684-73D6-4192-995E-36FAA521D409 Q28293089-E41AF8DB-4C02-4C8D-B658-EFF8A74258CA Q28305606-29F97E14-EDA3-496C-8F59-3F0B5B92069B Q28580222-1F9A38EF-FD72-4E9A-8446-F701AE2905C2 Q28751133-7DC85BE1-D313-432F-8388-09D3491503B9 Q30249189-A1B0B10E-D15D-455B-ACC6-E3CF1EF9BA56 Q30356872-34474318-CDEA-466F-B177-9EE3133E889C Q30428091-FEC9982E-1CF7-4C75-8E4B-4E3B9EBAC9CC Q30436776-9644FE07-3303-4619-8D1E-9FEED073343E Q30439719-6AE02BB4-3149-441C-BAE2-7D9AD55A407F Q30442446-01EAAA55-0B52-4FA0-A398-278B65D92091 Q30446679-0321D1C2-6DB8-4E1F-A0A5-C36FABCAE46B Q30447153-36FEFEB9-BF83-4A43-9137-EB821556F15F Q30467220-45274DC3-AA23-4832-A8BB-ABA2B45A2159 Q30470629-17199915-6145-494E-B530-09E0F4732A74 Q30474756-4E803E7C-34CF-48E1-B1D8-1DAC7308AAEF Q30481450-61D37994-E26C-46EF-B7DE-A5CDC6D70F21 Q30485730-26CB6D54-2E8C-4F44-909C-10E3E12D8E28

P2860

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.

http://www.wikidata.org/entity/Q34185186

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Antidepressant-like effects of ...... the forced swim test in rats.

@ast

Antidepressant-like effects of ...... the forced swim test in rats.

@en

Antidepressant-like effects of ...... the forced swim test in rats.

@nl

type

label

Antidepressant-like effects of ...... the forced swim test in rats.

@ast

Antidepressant-like effects of ...... the forced swim test in rats.

@en

Antidepressant-like effects of ...... the forced swim test in rats.

@nl

prefLabel

Antidepressant-like effects of ...... the forced swim test in rats.

@ast

Antidepressant-like effects of ...... the forced swim test in rats.

@en

Antidepressant-like effects of ...... the forced swim test in rats.

@nl

P1433

Q34185186-74CBEA5C-68A7-4AAE-BCE8-D99C05B79757

P1476

Q34185186-AE8EC3DB-A3AA-4C01-8D26-49CC40ED4AD1

P2093

Q34185186-2EF7F5BD-7FCB-45F6-96C8-4CE52D4C3C03

Q34185186-35F97CD4-AC94-4ACC-BDA0-5820DE99A202

Q34185186-39BA09B1-857B-4E6B-8E3B-2DCF234F2577

Q34185186-7223EC5D-4801-43B0-9A9B-D4B22CF2D982

Q34185186-7B65D2F8-42BF-4DBE-82F7-A6E66460823B

Q34185186-804AA394-9CFC-401A-9FFD-20A2F15D3477

Q34185186-9049F45A-E3C2-4F4A-87DB-B43BFCFFCA32

Q34185186-C9F41ADE-4111-4C01-AA70-0F81A85D3CFE

Q34185186-E168026C-4844-4C00-9305-A5B170DD44FF

P304

Q34185186-2DA5DA4D-562D-43CF-9183-D49C2F90765F

P31

Q34185186-0C65F591-5849-48B1-82D8-AF73732C058F

P356

Q34185186-27F20351-AD25-4EBE-94A3-49DAEE8AFC04

P407

Q34185186-21F49EF9-BD35-4838-A673-67E0B488AED2

P433

Q34185186-102CE7CA-2670-4F42-8016-8A3C574B0817

P478

Q34185186-B40313EC-A2B1-43DB-954D-DCB89EF725C4

P577

Q34185186-E4DB3124-C101-4993-AF0C-E21C87633CA5

P5875

Q34185186-C3E4A017-94C9-4E2F-B887-B9FF4B4D75F9

P698

Q34185186-78F365AD-D8F9-4740-A88B-1155231A51C1

P921

Q34185186-780fbb87-21d1-4e77-8a96-cb4be3b7e806

P356

JPET.102.046433

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Antidepressant-like effects of ...... the forced swim test in rats.

@en

P2093

Andrea M Pliakas

http://www.w3.org/2001/XMLSchema#string

Hilarie C Tomasiewicz

http://www.w3.org/2001/XMLSchema#string

Mark S Todtenkopf

http://www.w3.org/2001/XMLSchema#string

Philip S Portoghese

http://www.w3.org/2001/XMLSchema#string

Robert M Jones

http://www.w3.org/2001/XMLSchema#string

Stephen D Mague

http://www.w3.org/2001/XMLSchema#string

William A Carlezon

http://www.w3.org/2001/XMLSchema#string

William C Stevens

http://www.w3.org/2001/XMLSchema#string

Yan Zhang

http://www.w3.org/2001/XMLSchema#string

P304

323-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.102.046433

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7879085

http://www.w3.org/2001/XMLSchema#string

P698

12649385

http://www.w3.org/2001/XMLSchema#string

P921